Aurobindo Pharma plans to launch 50-60 products in US in FY21

▴ aurobindo-pharma-launch-5060-products-us-fy21
Aurobindo Pharma’s US business published a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20

Aurobindo Pharma is foreseen to launch 50 to 60 new products during the current year, notified N Govindarajan, MD of the company.

“We are expecting to launch around 50 to 60 products this year including injectables…Out of the 50 to 60 products that we are talking about, 25 products have already been approved,” he said during the latest earnings call earlier this month.

Aurobindo Pharma’s US business published a growth of 27 percent year-on-year to Rs 11,484 crore in FY20.

On a constant currency basis, it boosted by 26 percent year-after-year to around $1.62 billion led by development in volumes and new product launches.

The company has obtained final approval for six ANDAs and inaugurated four products in the fourth quarter of last fiscal.

For the full year, it has collected approval for 22 ANDAs and introduced 34 products across oral, injectable, and OTC segments, Govindarajan said.

Answering a query, he said that the company is scheduling to spend $150 to $200 million on capex in the current year.

Reports said that Aurobindo has spent Rs 958 crores towards research and growth in FY 20 which was 4.1 percent of its total revenues.

Govindarajan said the R&D expenditure would be 5.5 percent of the revenues for the current year.

Tags : #AurobindoPharma #USFDA

About the Author


Btech. Computer Science
MBA aspirant
Preparing for GMAT currently
Interests: AI, writing and books

Related Stories

Loading Please wait...

Trending Now

CSIR and Laxai Sciences partners for COVID clinical trialsJuly 08, 2020
Tech Mahindra's, Bhubaneswar office sealed ; COVID-19 cases detectedJuly 08, 2020
India might see 2.87 lakh Covid cases per day by February 2021 : MIT July 08, 2020
Assam: Total coronavirus cases at 13,336; death toll 16July 08, 2020
PHC Group increases stake in SciMed to strengthen business in AsiaJuly 07, 2020
“We cannot let the pandemic stop us”; Dr. Harsh VardhanJuly 07, 2020
Merck Foundation provided oncology training to African doctorsJuly 07, 2020
Johns Hopkins reports promising clinical data in COVID-19 ARDSJuly 07, 2020
Masks encouraged next Trump rally, says White HouseJuly 07, 2020
Life-Saving HIV drugs risk running out as COVID-19 hits supplies-WHO July 07, 2020
Beijing reports zero Coronavirus casesJuly 07, 2020
One of the first for clinical trial for COVID-19 vaccineJuly 07, 2020
Australia's second-biggest city under new coronavirus lockdownJuly 07, 2020
A temple offers pandemic-hit Vietnamese workersJuly 07, 2020
Harvard, Princeton to reopen, many students barred from campus housingJuly 07, 2020
Atlanta mayor tests positive for CoronavirusJuly 07, 2020
Boris Johnson under fire for home deaths blame gameJuly 07, 2020
View mask refusers like drunk drivers: leading scientistJuly 07, 2020
Mankind Pharma promotes ‘Atmanirbhar Bharat’ with new Anthem July 07, 2020
Health and nutrition in young women: preparing for next generationJuly 07, 2020